<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>471</ReferenceId>
        <DateLastUpdated>2016-11-03-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15364109</PubmedId>
            <Abstract>The P64k protein of Neisseria meningitidis has been reported as an immunological carrier for weak immunogens. This investigation was aimed at characterizing the T-cell response produced in primed mice and at identifying T helper cell epitopes within this molecule. BALB/c mice subcutaneously immunized with the recombinant antigen provided inguinal lymph node cells (LNC) that proliferated in the presence of P64k in a dose-dependent manner. Proliferating cells secreted IL-4 while the concentration of IL-12 remained unaltered in the culture supernatant. By testing a panel of 59 overlapping synthetic peptides spanning the entire sequence of the antigen a T-cell determinant was localized. Prime-boost and lymphoproliferation experiments, conducted with highly purified synthetic peptides, confirmed that the segment including amino acids 470-485 comprises a T-cell epitope within the P64k molecule.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>233-9</ArticlePages>
            <ArticleTitle>Cell mediated immune response elicited in mice after immunization with the P64k meningococcal protein: epitope mapping.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Gonz치lez</LastName>
                    <ForeName>Sonia</ForeName>
                </Author>
                <Author>
                    <LastName>Naz치bal</LastName>
                    <ForeName>Consuelo</ForeName>
                </Author>
                <Author>
                    <LastName>Rao</LastName>
                    <ForeName>Kanury V S</ForeName>
                </Author>
                <Author>
                    <LastName>Reyes</LastName>
                    <ForeName>Osvaldo</ForeName>
                </Author>
                <Author>
                    <LastName>Garay</LastName>
                    <ForeName>Hilda E</ForeName>
                </Author>
                <Author>
                    <LastName>Caballero</LastName>
                    <ForeName>Evelin</ForeName>
                </Author>
                <Author>
                    <LastName>Alvarez-Obreg칩n</LastName>
                    <ForeName>Julio C</ForeName>
                </Author>
                <Author>
                    <LastName>Sardi침as</LastName>
                    <ForeName>Gretel</ForeName>
                </Author>
                <Author>
                    <LastName>Silva</LastName>
                    <ForeName>Ricardo</ForeName>
                </Author>
            </Authors>
            <Affiliations>Center for Genetic Engineering and Biotechnology, P.O. Box 6162, Havana 10600, Cuba. sonia.gonzalez@cigb.edu.cu</Affiliations>
            <ArticleChemicalList>Bacterial Outer Membrane Proteins;Epitopes, T-Lymphocyte;Meningococcal Vaccines;Peptides;Recombinant Proteins;lpdA protein, Neisseria meningitidis</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Bacterial Outer Membrane Proteins(chemistry; genetics; immunology); Epitope Mapping; Epitopes, T-Lymphocyte(immunology); Female; Immunization; Lymph Nodes(chemistry; immunology); Lymphocyte Activation; Meningococcal Infections(prevention &amp; control); Meningococcal Vaccines(administration &amp; dosage; immunology); Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neisseria meningitidis(immunology); Peptides(chemistry; immunology); Recombinant Proteins(immunology); Th1 Cells(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>42</Volume>
                <Issue>2</Issue>
                <Title>FEMS immunology and medical microbiology</Title>
                <Issn>0928-8244</Issn>
                <MedlineTa>FEMS Immunol Med Microbiol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>P48A</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IPGVAYTSPEVAWVG</LinearSequence>
                        <StartingPosition>469</StartingPosition>
                        <EndingPosition>483</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAF41719.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>487</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 238</LocationOfData>
                <EpitopeId>27857</EpitopeId>
                <ReferenceStartingPosition>470</ReferenceStartingPosition>
                <ReferenceEndingPosition>485</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <TCellId>2687</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>6-8 weeks old</Age>
                                <MhcAlleleTypesPresent>
                                    <MhcAlleleId>169</MhcAlleleId>
                                </MhcAlleleTypesPresent>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IPGVAYTSPEVAWVG</LinearSequence>
                                            <StartingPosition>469</StartingPosition>
                                            <EndingPosition>483</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAF41719.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>487</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>P48A</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>Lymphocyte</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>169</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>P48A</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IPGVAYTSPEVAWVG</LinearSequence>
                                        <StartingPosition>469</StartingPosition>
                                        <EndingPosition>483</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAF41719.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>487</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>A series of 59 overlapping 20-mer peptides spanning the full-length of the P64k protein were used to scan for proliferation of lymphocytes from mice immunized with recombinant P64k. All but the 47th, 48th, and 49th peptides showed stimulation indices less than 2 and were considered to give negative responses.  The authors did not specify the sequences of these peptides.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

